1Belfiglio M,De Beradis G,Franciosi M,et al. The relationship between physicians'self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes.The QuED study Groupquality of care and outcomes in type 2 diabetes [J]. Diabetes Care, 2001,24(3 ) :423-429.
2Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes[J]. Diabetes Care, 2001,24( 4 ): 758-767.
3Wright A, Burden AC, Paisey RB ,et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K.Prospective Diabetes Study [J]. Diabetes Care, 2002,25 (2) : 330-336.
4Rosenstock J,Schwartz SL,Clark CM Jr, et al. Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine and NPH insulin[J]. Diabetes Care,2001,24(4) :631-636.
2Wright A, Burden AC, Paisey RB, et al. Sulfonylurea inadequacy : efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U. K. Prospective Diabetes Study [ J ]. Diabetes Care, 2002,25 ( 2 ) : 330- 336.
